Dimensional Fund Advisors
ABEO icon

Dimensional Fund Advisors’s Abeona Therapeutics ABEO Stock Holding History

Dimensional Fund Advisors’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$154K Buy
+34,371
New +$172K ﹤0.01% 3092
2023
Q4 		– Sell
-11,196
Closed -$47.1K – 3413
2023
Q3 		$47.1K Sell
11,196
-1,795
-14% -$6.79K ﹤0.01% 3386
2023
Q2 		$52.4K Hold
12,991
– – ﹤0.01% 3403
2023
Q1 		$36.6K Sell
12,991
-5,348
-29% -$14K ﹤0.01% 3407
2022
Q4 		$56 Sell
18,339
-15,644
-46% -$58.5K ﹤0.01% 3384
2022
Q3 		$103K Buy
+33,983
New +$140K ﹤0.01% 3323
2021
Q4 		– Sell
-6,459
Closed -$181K – 3538
2021
Q3 		$181K Sell
6,459
-627
-9% -$20.1K ﹤0.01% 3365
2021
Q2 		$277K Sell
7,086
-1,597
-18% -$65.2K ﹤0.01% 3274
2021
Q1 		$408K Sell
8,683
-2,014
-19% -$111K ﹤0.01% 3179
2020
Q4 		$420K Sell
10,697
-208
-2% -$7.08K ﹤0.01% 3120
2020
Q3 		$279K Buy
10,905
+1,707
+19% +$108K ﹤0.01% 3165
2020
Q2 		$670K Buy
9,198
+2,699
+42% +$187K ﹤0.01% 3021
2020
Q1 		$341K Sell
6,499
-153
-2% -$10.2K ﹤0.01% 3123
2019
Q4 		$544K Buy
6,652
+1,009
+18% +$71.2K ﹤0.01% 3125
2019
Q3 		$319K Buy
5,643
+2,094
+59% +$157K ﹤0.01% 3211
2019
Q2 		$424K Buy
3,549
+632
+22% +$106K ﹤0.01% 3217
2019
Q1 		$537K Hold
2,917
– – ﹤0.01% 3155
2018
Q4 		$521K Hold
2,917
– – ﹤0.01% 3138
2018
Q3 		$933K Buy
+2,917
New +$1.03M ﹤0.01% 3078
2018
Q1 		– Sell
-691
Closed -$274K – 3345
2017
Q4 		$274K Sell
691
-132
-16% -$54.6K ﹤0.01% 3173
2017
Q3 		$351K Hold
823
– – ﹤0.01% 3147
2017
Q2 		$132K Hold
823
– – ﹤0.01% 3230
2017
Q1 		$103K Sell
823
-96
-10% -$12.4K ﹤0.01% 3247
2016
Q4 		$111K Hold
919
– – ﹤0.01% 3231
2016
Q3 		$138K Buy
+919
New +$89.9K ﹤0.01% 3211

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors's ABEO Position: Q1 2026 in Review

Dimensional Fund Advisors opened a new position in Abeona Therapeutics (ABEO) in Q1 2026: 34,371 shares worth $154K. The stake represents ﹤0.01% of the portfolio and ranks #3092 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in ABEO as recently as Q3 2023.

Dimensional Fund Advisors first reported a position in ABEO in Q3 2016 and has held it in 25 quarters since. The position peaked at $933K in Q3 2018. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Dimensional Fund Advisors held 34,371 shares of Abeona Therapeutics worth $154K as of Q1 2026.
  • Abeona Therapeutics was a new Dimensional Fund Advisors position in Q1 2026.
  • Abeona Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3092 holding.
  • Dimensional Fund Advisors first reported a position in Abeona Therapeutics in Q3 2016 and has held it in 25 quarters since.
  • Dimensional Fund Advisors's Abeona Therapeutics position peaked at $933K in Q3 2018.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.